ImportRefusal LogoImportRefusal

CIPLA LTD.

⚠️ High Risk

FEI: 3014216386 • Rorathang, Sixkotic • INDIA

FEI

FEI Number

3014216386

📍

Location

Rorathang, Sixkotic

🇮🇳

Country

INDIA
🏢

Address

Taipin Block, , Rorathang, Sixkotic, India

High Risk

FDA Import Risk Assessment

58.4
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

3
Total Refusals
1
Unique Violations
1/21/2025
Latest Refusal
8/9/2018
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
22.3×30%
Recency
76.2×20%
Frequency
4.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
1/21/2025
60WCY26PIPERAZINE (ANTHELMINTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/9/2023
60MDB03ANILERIDINE HCL (ANALGESIC, NARCOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/9/2018
61FDA54CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is CIPLA LTD.'s FDA import refusal history?

CIPLA LTD. (FEI: 3014216386) has 3 FDA import refusal record(s) in our database, spanning from 8/9/2018 to 1/21/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. CIPLA LTD.'s FEI number is 3014216386.

What types of violations has CIPLA LTD. received?

CIPLA LTD. has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about CIPLA LTD. come from?

All FDA import refusal data for CIPLA LTD. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.